- About Us
Fortress Diagnostics’ Research and Development (R&D) team is committed to discovering and developing novel and innovative clinical testing solutions to provide the highest level of healthcare, globally, through continued investment in new technologies.
We reinvest a staggering 30% of turnover into R&D each year and since 2000 have developed a number of new clinical chemistry, coagulation, and immunoassay products from conception and clinical trials to regulatory clearance and full-scale production.
In addition, our team of highly-skilled and experienced scientists work to optimise our current product range by continuously improving existing performance claims therefore offering the best quality products on the market.
Our expert R&D team work collaboratively with many universities and research institutions including Queen’s University Belfast, the University of Cape Town and the University of Nottingham to develop custom tests, making new ideas a viable entity by utilising in-house resources at our UK-based ISO 13485:2016-accredited facility.
Fortress Diagnostics’ roots are firmly planted in strong technology that drives our company to advance science and medicine. As our understanding of the detection and development of new markers expands, our desire to bring about new cutting-edge technology and innovation to the diagnostic industry increases.
Morteza Afrasiabi, Managing Director, Fortress Diagnostics